KAV03503
Anti-Rabies Virus (RABV) Glycoprotein (G) Human IgM Antibody
Colorimetric
Plasma, Serum
Quantitative
93.75 - 6,000 ng/mL
22.1 ng/mL
CV<15%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Development and Evaluation of an Enzyme-Linked Immunosorbent Assay Targeting Rabies-Specific IgM and IgG in Human Sera., PMID:37112853
Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice., PMID:33985418
An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples., PMID:30403742
Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus., PMID:21044141
Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719., PMID:8577283
Mechanisms of rabies virus neutralization., PMID:7683158
Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene., PMID:8450236
Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation., PMID:8432980
Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein., PMID:2391499
Production of monoclonal antibodies against the Pasteur (P.V.) strain of rabies virus: problems and results., PMID:6526139
The advantage and adequacy of the mixed hemadsorption test for rabies antibody determination., PMID:355017
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
